No. 46 Improvement in Pain, Function and Quality of Life in Subacute Low Back Pain a Controlled Clinical Trial of Exercise vs. NSAIDS

PM&R ◽  
2014 ◽  
Vol 6 (8) ◽  
pp. S92
Author(s):  
Jesus Alberto Plata Contreras ◽  
Luz Elena Lugo Agudelo ◽  
Fabio Alonso Salinas Duran ◽  
Kelly De S. Payares
2013 ◽  
Vol 28 (4) ◽  
pp. 350-360 ◽  
Author(s):  
Pedro Ángel Baena-Beato ◽  
Enrique G Artero ◽  
Manuel Arroyo-Morales ◽  
Alejandro Robles-Fuentes ◽  
María Claudia Gatto-Cardia ◽  
...  

2020 ◽  
Author(s):  
Xuesong Hu ◽  
Shaoxing Dong ◽  
Bing Zhang ◽  
Xuan Wang ◽  
Yanwei Yin ◽  
...  

Abstract Background: Chronic nonspecific low back pain (CNSLBP) troubles approximately 30% of people worldwide. Silver needle therapy (SNT) is a treatment method to relieve soft tissue pain through heating. Therefore, this study aimed to observe the effects of SNT on CNSLBP.Methods: In this study, 100 patients were randomly divided into 2 groups: silver needle (SN) group and control group (n = 50). In the SN group, patients received SNT and physiotherapy, while patients received physiotherapy alone in the control group. At the 6-month follow-up, the numerical rating scale (NRS), Oswestry Disability Index (ODI), Short-Form 12 of quality of life (SF-12), the natural logarithms of low frequency measurement (InLF) and the natural logarithms of high frequency measurement (InHF) of heart rate variability (HRV) were recorded.Results: In both groups, NRS, ODI, SF-12 scores, and HRV at 2 weeks after treatment were improved and maintained for 6 months. Compared with the control group, more significant improvements were observed in the NRS and SF-12 scores at 1, 2, 3, and 6 months and in the ODI scores at 1 and 2 months in the SN group (P < 0.05). However, there was no significant difference between the groups in the ODI scores at 3 and 6 months. InLF and InHF in the SN group were higher than those in the control group at 3 and 6 months (P < 0.05).Conclusions: SNT relieved pain and improved quality of life and autonomic nerve activity, especially parasympathetic nerve, in patients with CNSLBP, without serious complications.Trial registration: This work has registered in the Chinese Clinical Trial Registry (No. ChiCTR-OOC-17013237; Date: 2017.11.09).


Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Xuesong Hu ◽  
Shaoxing Dong ◽  
Bing Zhang ◽  
Xuan Wang ◽  
Yanwei Yin ◽  
...  

Abstract Background Chronic nonspecific low back pain (CNSLBP) troubles approximately 30% of people worldwide. Silver needle therapy (SNT) is a treatment method to relieve soft tissue pain through heating. Therefore, this study aimed to observe the effects of SNT on CNSLBP. Methods In this study, 100 patients were randomly divided into 2 groups: silver needle (SN) group and control group (n = 50). In the SN group, patients received SNT and physiotherapy, while patients received physiotherapy alone in the control group. At the 6-month follow-up, the numerical rating scale (NRS), Oswestry Disability Index (ODI), Short-Form 12 of quality of life (SF-12), the natural logarithms of low-frequency measurement (InLF), and the natural logarithms of high-frequency measurement (InHF) of heart rate variability (HRV) were recorded. Results In both groups, NRS, ODI, SF-12 scores, and HRV at 2 weeks after treatment were improved and maintained for 6 months. Compared with the control group, more significant improvements were observed in the NRS and SF-12 scores at 1, 2, 3, and 6 months and in the ODI scores at 1 and 2 months in the SN group (P <  0.05). However, there was no significant difference between the groups in the ODI scores at 3 and 6 months. InLF and InHF in the SN group were higher than those in the control group at 3 and 6 months (P <  0.05). Conclusions SNT relieved pain and improved quality of life and autonomic nerve activity, especially parasympathetic nerve, in patients with CNSLBP, without serious complications. Trial registration Chinese Clinical Trial Registry No. ChiCTR-OOC-17013237. Registered on November 11, 2017.


2019 ◽  
Vol 26 (2) ◽  
pp. 80-92
Author(s):  
Michael Ofner ◽  
Martin Liebhauser ◽  
Harald Walach

Objective: Subacute low back pain is a frequent problem with the danger of chronification. Conventional treatment options are not always effective. Power Point therapy (PPT) is a novel approach that uses reflexological insights and can be easily applied by practitioners and patients. Methods: Randomized, active controlled study comparing 10 units of PPT of 10 min each, with 10 units of standard physiotherapy of 30 min each. Outcomes were functional scores (Roland Morris Disability, Oswestry, McGill Pain Questionnaire, Linton-Halldén – primary outcome) and health-related quality of life (SF-36), as well as blinded assessments by clinicians (secondary outcome). Results: Eighty patients consented and were randomized, 41 to PPT, 39 to physiotherapy. Measurements were taken at baseline, after the first and after the last treatment (approximately 5 weeks after enrolment). Multivariate linear models of covariance showed significant effects of time and group (p < 0.001) and for the quality of life variables also a significant interaction of time by group (p < 0.001). Clinician-documented variables showed significant differences at follow-up (p = 0.05 to p < 0.0001). Discussion: Both physiotherapy and PPT improve subacute low back pain significantly. PPT is likely more effective and should be studied further.


2014 ◽  
Vol 18 (1) ◽  
pp. 68-74 ◽  
Author(s):  
Jaqueline Borges ◽  
Abrahão Fontes Baptista ◽  
Nayara Santana ◽  
Israel Souza ◽  
Ramon A. Kruschewsky ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Wen-Cheng Lo ◽  
Yu Ting Chen ◽  
Chen Ching Chen

Introduction. Chronic low back pain (LBP) has a wide range of causes. However, most cases are induced by degeneration of the lumbar intervertebral discs (IVDs), and the aching caused by local compression of the affected region has considerable impacts on quality of life. This clinical trial investigated the use of Elgucare, a Chinese herbal formula, as a food supplement to reduce the pain of patients with LBP induced by degeneration of the lumbar IVDs. Methods. The study assessed patient subjective quality of life, functional limitations caused by LBP, and variations in pain. The assessment was done through the visual analogue scale (VAS) and effects on lumbar IVD thickness, water content, and bone mineral density (BMD). These parameters were evaluated before and after the administration of Elgucare or a placebo, one of which was taken by each participant for a 12-month period. Results. Elgucare reduced the patients’ mean VAS pain score by 2.25 points and improved their mean LBP-hampered mobility as assessed by the Roland-Morris Questionnaire by 5.17 points. The results of another questionnaire indicated that Elgucare slowed the LBP-induced deterioration of patients’ quality of life, while objective assessment indices obtained through X-ray and magnetic resonance imaging showed that the height and water retention of their IVDs were increased. However, the BMD results showed no improvements. Conclusions. Elgucare can increase the water retention and height of IVDs and reduce LBP, thereby enhancing quality of life. Therefore, Elgucare can potentially be used as a clinical supplement.


Sign in / Sign up

Export Citation Format

Share Document